Cardio-Oncology

Cardio-oncology is the intersection of heart failure conditions in patients who have been treated for cancer. New insights into however cancer therapies impact cardiovascular physiological condition and long-run effects on cancer survivors. In view of trends, similarly because the cardiovascular toxicity potential of radiation and therapy, cancer patients square measure exposed to vas morbidity and mortality over ever before. Anticancer therapies will cause important injury to the vasculature, leading to angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure (HF), independently from the direct myocardial or pericardial damage that might occur. Moreover, cancer is mostly related to a hypercoagulable state, that will increase the danger of acute thrombotic events.

    Related Conference of Cardio-Oncology

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    7th World Heart and Brain Conference

    London, UK
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    October 17-18, 2024

    8th Annual Heart Rhythm Conference

    Barcelona, Spain
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland

    Cardio-Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in